EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

olyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial

Mohammadreza Naderian, Heshmatollah Akbari, Morteza Saeedi, Amir Ali Sohrabpour

Middle East Journal of Digestive Diseases · 10.01.2017 · 9 (1) · 12-19

DOI: 10.15171/mejdd.2016.46 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Middle East Journal of Digestive Diseases, online erschienen am 10.01.2017. Verfasst von Mohammadreza Naderian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Liver and Pancreaticobilliary Disease Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences…. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Hepatic EncephalopathyLactuloseLaxativesLiver CirrhosisPolyethylene Glycols

Autor:innen und Institutionen

  • Liver and Pancreaticobilliary Disease Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Non-Communicable Diseases Research Center, Endocrinolo…
  • Liver and Pancreaticobilliary Disease Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Emergency Medicine, Pre-Hospital Emergency Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Naderian, M., Akbari, H., Saeedi, M., & Sohrabpour, A. A. (2017). olyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial. Middle East Journal of Digestive Diseases, 9(1), 12-19. https://doi.org/10.15171/mejdd.2016.46

Vancouver

Naderian M, Akbari H, Saeedi M, Sohrabpour AA. olyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial. Middle East Journal of Digestive Diseases. 2017;9(1):12-19. doi:10.15171/mejdd.2016.46

BibTeX
@article{Naderian2017,
  author = {Naderian, Mohammadreza and Akbari, Heshmatollah and Saeedi, Morteza and Sohrabpour, Amir Ali},
  title = {olyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial},
  journal = {Middle East Journal of Digestive Diseases},
  year = {2017},
  volume = {9},
  number = {1},
  pages = {12--19},
  doi = {10.15171/mejdd.2016.46}
}
Kostenlos starten →